Texas academic and research investigators are invited to submit pilot grant proposals focused on cancer comparative effectiveness research. Proposals covering screening, diagnosis, treatment, post-treatment surveillance, or survivorship are encouraged. Funding will be provided for one year, up to $20,000 in direct costs. Register for option info sessions on June 3 or 7, 2024.

Since 2010 we have worked closely with the Texas Cancer Registry (TCR) to combine information from various large databases like Medicare and Medicaid for research purposes. Our goals have evolved to include connecting TCR databases with national surveys to improve research on patient outcomes. We also aim to train new researchers in comparative effectiveness research (CER) across Texas, especially those who are underrepresented. Join us for a workshop on May 22, 2024, to learn more. Consultation appointments are available May 23-24. Register today!

Please join us for a DMAC CERCIT seminar presented by Andrew B. Lawson PhD, Professor of Biostatistics, Department of Public Health Sciences, College of Medicine,Medical University of South Carolina

A new video is now available for the DMAC CERCIT Seminar Series: Using linked registry-claims-survey data to study late effects of cancer treatment Presented by Dr. Sharon Giordano, MD, MPH, FASCO, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX. PASSWORD: UAzu#&c0